Free Trial
NASDAQ:TVGN

Tevogen Bio (TVGN) Stock Price, News & Analysis

Tevogen Bio logo
$0.67 -0.11 (-13.54%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$0.67 0.00 (-0.28%)
As of 10/3/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Tevogen Bio Stock (NASDAQ:TVGN)

Advanced

Key Stats

Today's Range
$0.65
$0.79
50-Day Range
$0.67
$1.08
52-Week Range
$0.26
$3.09
Volume
1.74 million shs
Average Volume
510,118 shs
Market Capitalization
$132.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Consensus Rating
Hold

Company Overview

Tevogen Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

TVGN MarketRank™: 

Tevogen Bio scored higher than 50% of companies evaluated by MarketBeat, and ranked 575th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tevogen Bio has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Tevogen Bio has a consensus price target of $10.00, representing about 1,383.9% upside from its current price of $0.67.

  • Amount of Analyst Coverage

    Tevogen Bio has only been the subject of 2 research reports in the past 90 days.

  • Read more about Tevogen Bio's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tevogen Bio is -3.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tevogen Bio is -3.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Tevogen Bio's valuation and earnings.
  • Percentage of Shares Shorted

    4.91% of the float of Tevogen Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Tevogen Bio has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tevogen Bio has recently decreased by 13.38%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Tevogen Bio does not currently pay a dividend.

  • Dividend Growth

    Tevogen Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.91% of the float of Tevogen Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Tevogen Bio has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tevogen Bio has recently decreased by 13.38%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Tevogen Bio has a news sentiment score of -0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Tevogen Bio this week, compared to 4 articles on an average week.
  • Search Interest

    Only 5 people have searched for TVGN on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Tevogen Bio to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tevogen Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    73.24% of the stock of Tevogen Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Tevogen Bio's insider trading history.
Receive TVGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tevogen Bio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TVGN Stock News Headlines

Tevogen Bio (NASDAQ:TVGN) Stock Price Down 0.3% - What's Next?
Tevogen Bio Faces Nasdaq Delisting Notice
Gold surges past $3,600 … but this has beat gold by 1,000x
Gold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real opportunity isn’t in coins or bullion. In every major gold rally of the past 50 years, there’s been another investment that has delivered dramatically higher returns.tc pixel
See More Headlines

TVGN Stock Analysis - Frequently Asked Questions

Tevogen Bio's stock was trading at $1.03 at the beginning of the year. Since then, TVGN shares have decreased by 34.6% and is now trading at $0.6739.

Tevogen Bio Holdings Inc. (NASDAQ:TVGN) announced its quarterly earnings data on Tuesday, August, 19th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.05) by $0.02.

Shares of TVGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tevogen Bio investors own include NVIDIA (NVDA), Candel Therapeutics (CADL), CXApp (CXAI), GlycoMimetics (GLYC), Rigetti Computing (RGTI), XTI Aerospace (XTIA) and Aldeyra Therapeutics (ALDX).

Company Calendar

Last Earnings
8/19/2025
Today
10/03/2025
Next Earnings (Estimated)
11/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TVGN
Previous Symbol
NASDAQ:TVGN
CIK
1860871
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$10.00
Potential Upside/Downside
+1,383.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$13.73 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-775.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.26
Quick Ratio
0.26

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.09) per share
Price / Book
-7.49

Miscellaneous

Outstanding Shares
196,710,000
Free Float
52,638,000
Market Cap
$132.56 million
Optionable
N/A
Beta
-0.83
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:TVGN) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners